IO Biotech CSO speaks at Cancer Biotherapeutics Conference
On 14-15 March 2016, London sets the scene for Cambridge Healthtech Institute's Inaugural conference, Cancer Biotherapeutics, presenting new developments, in-depth discussions and focused short courses from academia and industry with a strong focus on immunotherapy.
In the overall category Immuno-Oncology, IO Biotech CSO, Professor Mads Hald Andersen, has been invited to speak about the topic 'Anti-Regulatory T Cells: An Alternative Approach to Target Immunosuppressive Mechanisms'.
Mads Hald Andersen will be presenting on Monday 14 March at 4.30p.m.
For more information about Cancer Biotherapeutics, Cancer Biotherapeutics.